Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease

NCT00172809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C
End Stage Renal Disease

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Interferon alfa-2a

Sponsor

National Taiwan University Hospital